- Rank in Search Criteria: 301
World Rank (Jan-05-2024): 11,454
World Rank (Jul-30-2023): 11454
World Rank (Jan-2022): 11,454
Market Cap (Jan-2022): 0.70 Billion USDAnnual Revenue in USD: 276 Million USD
Annual Net Income in USD: 133 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 302
World Rank (Jan-05-2024): 11,473
Market Cap (Jan-05-2024): 0.60 Billion USD
World Rank (Jul-30-2023): 11279
Market Cap (Jul-30-2023): 0.63 Billion USD
World Rank (Jan-2022): 9,882
Market Cap (Jan-2022): 0.92 Billion USDAnnual Revenue in USD: 81 Million USD
Annual Net Income in USD: 145 Million USD
Annual Results for Period ending: Mar-2022 ending year
- Rank in Search Criteria: 303
World Rank (Jan-05-2024): 11,487
Market Cap (Jan-05-2024): 0.60 Billion USD
World Rank (Jul-30-2023): 13003
Market Cap (Jul-30-2023): 0.48 Billion USD
World Rank (Jan-2022): 7,449
Market Cap (Jan-2022): 1.49 Billion USDAnnual Revenue in USD: 17 Million USD
Annual Net Income in USD: -12 Million USD
Annual Results for Period ending: Jun-2022 ending yearCompany Profile: Imugene is a Clinical Stage Immuno Oncology company develops transformative cancer medicines. The headquarters is in Australia.
- Rank in Search Criteria: 304
World Rank (Jan-05-2024): 11,508
Market Cap (Jan-05-2024): 0.60 Billion USD
World Rank (Jul-30-2023): 12269
Market Cap (Jul-30-2023): 0.54 Billion USD
World Rank (Jan-2022): 17,252
Market Cap (Jan-2022): 0.27 Billion USDAnnual Revenue in USD: 604 Million USD
Annual Net Income in USD: 16 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 305
World Rank (Jan-05-2024): 11,538
Market Cap (Jan-05-2024): 0.60 Billion USD
World Rank (Jul-30-2023): 11747
Market Cap (Jul-30-2023): 0.59 Billion USD
World Rank (Jan-2022): 11,777
Market Cap (Jan-2022): 0.66 Billion USDAnnual Revenue in USD: 191 Million USD
Annual Net Income in USD: 94 Million USD
Annual Results for Period ending: Mar-2022 ending year
- Rank in Search Criteria: 306
World Rank (Jan-05-2024): 11,666
Market Cap (Jan-05-2024): 0.58 Billion USD
World Rank (Jul-30-2023): 14830
Market Cap (Jul-30-2023): 0.35 Billion USD
World Rank (Jan-2022): 17,442
Market Cap (Jan-2022): 0.27 Billion USD
- Rank in Search Criteria: 307
World Rank (Jan-05-2024): 11,687
Market Cap (Jan-05-2024): 0.58 Billion USD
World Rank (Jul-30-2023): 11732
Market Cap (Jul-30-2023): 0.59 Billion USD
- Rank in Search Criteria: 308
World Rank (Jan-05-2024): 11,699
World Rank (Jul-30-2023): 11699
World Rank (Jan-2022): 11,699
- Rank in Search Criteria: 309
World Rank (Jan-05-2024): 11,774
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 12840
Market Cap (Jul-30-2023): 0.49 Billion USD
World Rank (Jan-2022): 11,275
Market Cap (Jan-2022): 0.72 Billion USDAnnual Revenue in USD: 348 Million USD
Annual Net Income in USD: -7 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 310
World Rank (Jan-05-2024): 11,786
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 13994
Market Cap (Jul-30-2023): 0.41 Billion USD
World Rank (Jan-2022): 15,803
Market Cap (Jan-2022): 0.35 Billion USDCompany Profile: Ridley Corporation is Australia’s provider of high performance animal nutrition solutions. Ridley has been an integral part of Australian agriculture for almost 30 years, building strong partnerships with suppliers, customers and local communities.